IGF-1 LR3

🔹 What is IGF-1 LR3?

Class: Synthetic long-acting analog of Insulin-like Growth Factor 1 (IGF-1). Mechanism:

• Binds to the IGF-1 receptor, mimicking endogenous IGF-1, promoting cellular growth, differentiation, and tissue repair.
• Long-arginine substitution (LR3) increases half-life (~20–30 hours), allowing sustained tissue exposure compared to native IGF-1.
• Stimulates muscle protein synthesis, bone growth, connective tissue repair, and recovery.
• Differs structurally from native IGF-1 by carrying an arginine instead of a glutamic acid at the third amino acid position (“arginine 3”), plus an additional sequence extension. This is what gives IGF-1 LR3 its much longer half-life and reduced binding to IGF-binding proteins (IGFBPs) compared to native IGF-1 — the reason it’s used over native IGF-1 in practice.

Primary focus: Muscle hypertrophy, tissue repair, connective tissue regeneration, recovery from injury, and anti-aging support.

---

🔹 Oral Dosage: Not effective; IGF-1 peptides are degraded in the GI tract. Only injectable/subcutaneous administration is practical.

---

🔹 Injectable / Subcutaneous Dosage (most common) Range:

• Typical dosing: 20–50 µg per day, divided into 1–2 injections.
• Often adjusted based on body weight and goals; some advanced users go slightly higher, but doses above ~100 µg/day are rare in anecdotal reports.

Frequency:

• Daily injections are common; can be pre- or post-workout to maximize anabolic and regenerative effects.

Rationale: Sustained exposure via LR3 modification allows low daily dosing to support muscle and connective tissue without excessive receptor overstimulation.

Alternative route — sublingual troche: Some clinical protocols use a sublingual troche instead of injection. Female dosing example: 50 mcg sublingual troche every other day x 4 weeks.

---

🔹 Cycle Length Common cycle length: 4–8 weeks for muscle hypertrophy or regenerative protocols. Off-cycle: 2–4 weeks to avoid receptor downregulation and assess tissue adaptation.

---

🔹 Optimal Dosing Window

• Post-workout: Enhances tissue repair and anabolic signaling.
• Morning dosing: Can support overall daily growth and recovery.
• Avoid late-night dosing if combined with GH secretagogues to prevent overlapping GH peaks.

---

✅ Educational Integration Example (injectable / subcutaneous)

• Example protocol: 25 µg IGF-1 LR3 post-workout daily for 6 weeks, followed by a 2-week break.
• Pair with: Resistance training, protein-rich diet, and supportive peptides (BPC-157, TB-500, GHK-Cu) for connective tissue repair.

---

🔹 Stacking Strategy (Educational / Complementary) Since IGF-1 LR3 directly stimulates anabolic and regenerative pathways, complementary stacks focus on synergistic GH/IGF axis activation, tissue repair, and metabolic support: 🔸 GH Axis Synergy:

• CJC-1295 / Ipamorelin or Hexarelin: Increase endogenous GH pulses, which can enhance IGF-1 mediated effects.

🔸 Tissue & Connective Repair:

• BPC-157, TB-500, GHK-Cu: Promote tendon, ligament, and connective tissue repair, complementing IGF-1’s anabolic signaling.
• Collagen, Vitamin C, and minerals (zinc, magnesium): Provide substrates for tissue remodeling.

🔸 Metabolic & Recovery Support:

• NAD⁺ precursors (NMN, NR) and mitochondrial cofactors: Support cellular energy for IGF-1-driven growth.
• Adequate sleep and recovery protocols: Maximize anabolic environment.

Rationale: IGF-1 LR3 maximizes tissue repair and anabolic signaling; stacking focuses on supportive peptides, GH secretagogues, and nutrients to enhance efficacy and safety.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.